nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—Faeces discoloured—Octreotide—thymus cancer	0.0389	0.0681	CcSEcCtD
Boceprevir—CTSL—neck—thymus cancer	0.0191	0.053	CbGeAlD
Boceprevir—Goitre—Octreotide—thymus cancer	0.0189	0.0331	CcSEcCtD
Boceprevir—CTSV—hematopoietic system—thymus cancer	0.0174	0.0483	CbGeAlD
Boceprevir—CMA1—hematopoietic system—thymus cancer	0.0166	0.0461	CbGeAlD
Boceprevir—Ear infection—Octreotide—thymus cancer	0.0159	0.0278	CcSEcCtD
Boceprevir—Proctalgia—Octreotide—thymus cancer	0.0144	0.0252	CcSEcCtD
Boceprevir—CTSL—hematopoietic system—thymus cancer	0.0142	0.0394	CbGeAlD
Boceprevir—CTSL—epithelium—thymus cancer	0.013	0.036	CbGeAlD
Boceprevir—CTSV—pituitary gland—thymus cancer	0.0129	0.0358	CbGeAlD
Boceprevir—CTSS—neck—thymus cancer	0.0126	0.035	CbGeAlD
Boceprevir—Anorectal discomfort—Octreotide—thymus cancer	0.0123	0.0216	CcSEcCtD
Boceprevir—CTSV—lymphoid tissue—thymus cancer	0.0123	0.034	CbGeAlD
Boceprevir—Cholecystitis—Octreotide—thymus cancer	0.0117	0.0206	CcSEcCtD
Boceprevir—CMA1—lymphoid tissue—thymus cancer	0.0117	0.0324	CbGeAlD
Boceprevir—Haemorrhoids—Octreotide—thymus cancer	0.0115	0.0201	CcSEcCtD
Boceprevir—CTSV—thyroid gland—thymus cancer	0.0111	0.0309	CbGeAlD
Boceprevir—CTSL—cardiac atrium—thymus cancer	0.0108	0.0299	CbGeAlD
Boceprevir—CTSK—hematopoietic system—thymus cancer	0.0107	0.0297	CbGeAlD
Boceprevir—CMA1—bone marrow—thymus cancer	0.0107	0.0295	CbGeAlD
Boceprevir—CTSL—pituitary gland—thymus cancer	0.0106	0.0292	CbGeAlD
Boceprevir—Hypothyroidism—Octreotide—thymus cancer	0.0105	0.0184	CcSEcCtD
Boceprevir—CTSV—lung—thymus cancer	0.0101	0.028	CbGeAlD
Boceprevir—CTSL—lymphoid tissue—thymus cancer	0.01	0.0278	CbGeAlD
Boceprevir—Paranoia—Octreotide—thymus cancer	0.00989	0.0173	CcSEcCtD
Boceprevir—Neuralgia—Octreotide—thymus cancer	0.0097	0.017	CcSEcCtD
Boceprevir—CMA1—lung—thymus cancer	0.00966	0.0268	CbGeAlD
Boceprevir—Metrorrhagia—Octreotide—thymus cancer	0.00944	0.0165	CcSEcCtD
Boceprevir—CTSS—hematopoietic system—thymus cancer	0.00939	0.026	CbGeAlD
Boceprevir—CTSL—bone marrow—thymus cancer	0.00912	0.0253	CbGeAlD
Boceprevir—CTSL—thyroid gland—thymus cancer	0.0091	0.0252	CbGeAlD
Boceprevir—Otitis media—Octreotide—thymus cancer	0.00866	0.0152	CcSEcCtD
Boceprevir—CTSL—Extracellular matrix organization—MUSK—thymus cancer	0.00862	0.126	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—MUSK—thymus cancer	0.00862	0.126	CbGpPWpGaD
Boceprevir—CTSL—lung—thymus cancer	0.00826	0.0229	CbGeAlD
Boceprevir—CTSK—cardiac atrium—thymus cancer	0.00814	0.0226	CbGeAlD
Boceprevir—Endocrine disorder—Octreotide—thymus cancer	0.00813	0.0142	CcSEcCtD
Boceprevir—CMA1—Extracellular matrix organization—MUSK—thymus cancer	0.00801	0.117	CbGpPWpGaD
Boceprevir—CTSK—pituitary gland—thymus cancer	0.00795	0.022	CbGeAlD
Boceprevir—Amenorrhoea—Octreotide—thymus cancer	0.00767	0.0134	CcSEcCtD
Boceprevir—CTSK—lymphoid tissue—thymus cancer	0.00755	0.0209	CbGeAlD
Boceprevir—Rectal haemorrhage—Octreotide—thymus cancer	0.00746	0.0131	CcSEcCtD
Boceprevir—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00741	0.013	CcSEcCtD
Boceprevir—Oropharyngeal pain—Octreotide—thymus cancer	0.00741	0.013	CcSEcCtD
Boceprevir—Cellulitis—Octreotide—thymus cancer	0.00741	0.013	CcSEcCtD
Boceprevir—Herpes simplex—Octreotide—thymus cancer	0.00731	0.0128	CcSEcCtD
Boceprevir—CTSK—Extracellular matrix organization—MUSK—thymus cancer	0.00714	0.104	CbGpPWpGaD
Boceprevir—Hearing impaired—Octreotide—thymus cancer	0.00708	0.0124	CcSEcCtD
Boceprevir—CTSS—pituitary gland—thymus cancer	0.00697	0.0193	CbGeAlD
Boceprevir—CTSK—bone marrow—thymus cancer	0.00687	0.019	CbGeAlD
Boceprevir—CTSK—thyroid gland—thymus cancer	0.00685	0.019	CbGeAlD
Boceprevir—Injection site reaction—Octreotide—thymus cancer	0.0067	0.0117	CcSEcCtD
Boceprevir—CTSS—lymphoid tissue—thymus cancer	0.00661	0.0183	CbGeAlD
Boceprevir—CMA1—lymph node—thymus cancer	0.00661	0.0183	CbGeAlD
Boceprevir—Influenza like illness—Octreotide—thymus cancer	0.00655	0.0115	CcSEcCtD
Boceprevir—Wheezing—Octreotide—thymus cancer	0.00655	0.0115	CcSEcCtD
Boceprevir—Candida infection—Octreotide—thymus cancer	0.00643	0.0113	CcSEcCtD
Boceprevir—CTSK—lung—thymus cancer	0.00622	0.0172	CbGeAlD
Boceprevir—Mouth ulceration—Octreotide—thymus cancer	0.00609	0.0107	CcSEcCtD
Boceprevir—CTSS—bone marrow—thymus cancer	0.00602	0.0167	CbGeAlD
Boceprevir—CTSS—thyroid gland—thymus cancer	0.00601	0.0166	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—MUSK—thymus cancer	0.00588	0.086	CbGpPWpGaD
Boceprevir—Sleep disorder—Octreotide—thymus cancer	0.00565	0.0099	CcSEcCtD
Boceprevir—CTSL—lymph node—thymus cancer	0.00565	0.0157	CbGeAlD
Boceprevir—Diabetes mellitus—Octreotide—thymus cancer	0.00562	0.00986	CcSEcCtD
Boceprevir—Gastroenteritis—Octreotide—thymus cancer	0.00552	0.00967	CcSEcCtD
Boceprevir—Deafness—Octreotide—thymus cancer	0.00547	0.00958	CcSEcCtD
Boceprevir—CTSS—lung—thymus cancer	0.00545	0.0151	CbGeAlD
Boceprevir—Nasal congestion—Octreotide—thymus cancer	0.00537	0.00941	CcSEcCtD
Boceprevir—Amnesia—Octreotide—thymus cancer	0.00521	0.00912	CcSEcCtD
Boceprevir—Arthritis—Octreotide—thymus cancer	0.00503	0.00882	CcSEcCtD
Boceprevir—Pain in extremity—Octreotide—thymus cancer	0.00489	0.00857	CcSEcCtD
Boceprevir—Psychotic disorder—Octreotide—thymus cancer	0.00478	0.00837	CcSEcCtD
Boceprevir—Irritability—Octreotide—thymus cancer	0.00467	0.00818	CcSEcCtD
Boceprevir—Dehydration—Octreotide—thymus cancer	0.00455	0.00797	CcSEcCtD
Boceprevir—Dry skin—Octreotide—thymus cancer	0.00448	0.00786	CcSEcCtD
Boceprevir—Abdominal pain upper—Octreotide—thymus cancer	0.00447	0.00783	CcSEcCtD
Boceprevir—Nasopharyngitis—Octreotide—thymus cancer	0.00438	0.00767	CcSEcCtD
Boceprevir—Gastritis—Octreotide—thymus cancer	0.00433	0.00759	CcSEcCtD
Boceprevir—Muscular weakness—Octreotide—thymus cancer	0.00432	0.00756	CcSEcCtD
Boceprevir—CTSK—lymph node—thymus cancer	0.00426	0.0118	CbGeAlD
Boceprevir—Abdominal distension—Octreotide—thymus cancer	0.00426	0.00746	CcSEcCtD
Boceprevir—Influenza—Octreotide—thymus cancer	0.00423	0.00741	CcSEcCtD
Boceprevir—Pancreatitis—Octreotide—thymus cancer	0.00415	0.00726	CcSEcCtD
Boceprevir—Bronchitis—Octreotide—thymus cancer	0.00407	0.00713	CcSEcCtD
Boceprevir—Abdominal discomfort—Octreotide—thymus cancer	0.00405	0.0071	CcSEcCtD
Boceprevir—Dysuria—Octreotide—thymus cancer	0.00395	0.00693	CcSEcCtD
Boceprevir—Pollakiuria—Octreotide—thymus cancer	0.00391	0.00684	CcSEcCtD
Boceprevir—Weight decreased—Octreotide—thymus cancer	0.00383	0.0067	CcSEcCtD
Boceprevir—Hyperglycaemia—Octreotide—thymus cancer	0.00381	0.00668	CcSEcCtD
Boceprevir—Pneumonia—Octreotide—thymus cancer	0.00379	0.00664	CcSEcCtD
Boceprevir—Depression—Octreotide—thymus cancer	0.00376	0.00659	CcSEcCtD
Boceprevir—CTSS—lymph node—thymus cancer	0.00373	0.0103	CbGeAlD
Boceprevir—Neuropathy peripheral—Octreotide—thymus cancer	0.0037	0.00648	CcSEcCtD
Boceprevir—Urinary tract infection—Octreotide—thymus cancer	0.00366	0.00642	CcSEcCtD
Boceprevir—Conjunctivitis—Octreotide—thymus cancer	0.00366	0.00642	CcSEcCtD
Boceprevir—Hepatobiliary disease—Octreotide—thymus cancer	0.00357	0.00625	CcSEcCtD
Boceprevir—Epistaxis—Octreotide—thymus cancer	0.00356	0.00623	CcSEcCtD
Boceprevir—Sinusitis—Octreotide—thymus cancer	0.00354	0.0062	CcSEcCtD
Boceprevir—Rhinitis—Octreotide—thymus cancer	0.00339	0.00595	CcSEcCtD
Boceprevir—Hypoaesthesia—Octreotide—thymus cancer	0.00337	0.0059	CcSEcCtD
Boceprevir—Pharyngitis—Octreotide—thymus cancer	0.00336	0.00589	CcSEcCtD
Boceprevir—Oedema peripheral—Octreotide—thymus cancer	0.00333	0.00584	CcSEcCtD
Boceprevir—Visual impairment—Octreotide—thymus cancer	0.00326	0.00571	CcSEcCtD
Boceprevir—Tinnitus—Octreotide—thymus cancer	0.00316	0.00553	CcSEcCtD
Boceprevir—Flushing—Octreotide—thymus cancer	0.00314	0.0055	CcSEcCtD
Boceprevir—Cardiac disorder—Octreotide—thymus cancer	0.00314	0.0055	CcSEcCtD
Boceprevir—CYP3A5—hematopoietic system—thymus cancer	0.00312	0.00864	CbGeAlD
Boceprevir—Immune system disorder—Octreotide—thymus cancer	0.00306	0.00536	CcSEcCtD
Boceprevir—Arrhythmia—Octreotide—thymus cancer	0.00302	0.0053	CcSEcCtD
Boceprevir—Alopecia—Octreotide—thymus cancer	0.00299	0.00524	CcSEcCtD
Boceprevir—Mental disorder—Octreotide—thymus cancer	0.00297	0.0052	CcSEcCtD
Boceprevir—Erythema—Octreotide—thymus cancer	0.00295	0.00516	CcSEcCtD
Boceprevir—Malnutrition—Octreotide—thymus cancer	0.00295	0.00516	CcSEcCtD
Boceprevir—Flatulence—Octreotide—thymus cancer	0.0029	0.00509	CcSEcCtD
Boceprevir—Back pain—Octreotide—thymus cancer	0.00285	0.00499	CcSEcCtD
Boceprevir—Muscle spasms—Octreotide—thymus cancer	0.00283	0.00496	CcSEcCtD
Boceprevir—Vision blurred—Octreotide—thymus cancer	0.00278	0.00487	CcSEcCtD
Boceprevir—Ill-defined disorder—Octreotide—thymus cancer	0.00273	0.00479	CcSEcCtD
Boceprevir—Anaemia—Octreotide—thymus cancer	0.00272	0.00477	CcSEcCtD
Boceprevir—Agitation—Octreotide—thymus cancer	0.00271	0.00474	CcSEcCtD
Boceprevir—Malaise—Octreotide—thymus cancer	0.00266	0.00466	CcSEcCtD
Boceprevir—Vertigo—Octreotide—thymus cancer	0.00265	0.00464	CcSEcCtD
Boceprevir—Syncope—Octreotide—thymus cancer	0.00264	0.00463	CcSEcCtD
Boceprevir—Palpitations—Octreotide—thymus cancer	0.0026	0.00456	CcSEcCtD
Boceprevir—Loss of consciousness—Octreotide—thymus cancer	0.00259	0.00454	CcSEcCtD
Boceprevir—Cough—Octreotide—thymus cancer	0.00257	0.0045	CcSEcCtD
Boceprevir—Hypertension—Octreotide—thymus cancer	0.00254	0.00446	CcSEcCtD
Boceprevir—Myalgia—Octreotide—thymus cancer	0.00251	0.0044	CcSEcCtD
Boceprevir—Arthralgia—Octreotide—thymus cancer	0.00251	0.0044	CcSEcCtD
Boceprevir—Chest pain—Octreotide—thymus cancer	0.00251	0.0044	CcSEcCtD
Boceprevir—Anxiety—Octreotide—thymus cancer	0.0025	0.00438	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00249	0.00436	CcSEcCtD
Boceprevir—Discomfort—Octreotide—thymus cancer	0.00248	0.00434	CcSEcCtD
Boceprevir—Dry mouth—Octreotide—thymus cancer	0.00245	0.0043	CcSEcCtD
Boceprevir—Infection—Octreotide—thymus cancer	0.00239	0.00419	CcSEcCtD
Boceprevir—Shock—Octreotide—thymus cancer	0.00237	0.00415	CcSEcCtD
Boceprevir—Nervous system disorder—Octreotide—thymus cancer	0.00236	0.00413	CcSEcCtD
Boceprevir—Thrombocytopenia—Octreotide—thymus cancer	0.00235	0.00413	CcSEcCtD
Boceprevir—Tachycardia—Octreotide—thymus cancer	0.00235	0.00411	CcSEcCtD
Boceprevir—CYP3A4—hematopoietic system—thymus cancer	0.00234	0.00649	CbGeAlD
Boceprevir—Skin disorder—Octreotide—thymus cancer	0.00234	0.00409	CcSEcCtD
Boceprevir—Hyperhidrosis—Octreotide—thymus cancer	0.00232	0.00407	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00219	0.00384	CcSEcCtD
Boceprevir—Insomnia—Octreotide—thymus cancer	0.00217	0.00381	CcSEcCtD
Boceprevir—Paraesthesia—Octreotide—thymus cancer	0.00216	0.00378	CcSEcCtD
Boceprevir—Dyspnoea—Octreotide—thymus cancer	0.00214	0.00376	CcSEcCtD
Boceprevir—Dyspepsia—Octreotide—thymus cancer	0.00212	0.00371	CcSEcCtD
Boceprevir—Decreased appetite—Octreotide—thymus cancer	0.00209	0.00366	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Octreotide—thymus cancer	0.00208	0.00364	CcSEcCtD
Boceprevir—Fatigue—Octreotide—thymus cancer	0.00207	0.00363	CcSEcCtD
Boceprevir—Pain—Octreotide—thymus cancer	0.00206	0.0036	CcSEcCtD
Boceprevir—Constipation—Octreotide—thymus cancer	0.00206	0.0036	CcSEcCtD
Boceprevir—Feeling abnormal—Octreotide—thymus cancer	0.00198	0.00347	CcSEcCtD
Boceprevir—Gastrointestinal pain—Octreotide—thymus cancer	0.00197	0.00345	CcSEcCtD
Boceprevir—Urticaria—Octreotide—thymus cancer	0.00191	0.00335	CcSEcCtD
Boceprevir—Abdominal pain—Octreotide—thymus cancer	0.0019	0.00333	CcSEcCtD
Boceprevir—Body temperature increased—Octreotide—thymus cancer	0.0019	0.00333	CcSEcCtD
Boceprevir—CYP3A5—lung—thymus cancer	0.00181	0.00502	CbGeAlD
Boceprevir—Hypersensitivity—Octreotide—thymus cancer	0.00177	0.0031	CcSEcCtD
Boceprevir—Asthenia—Octreotide—thymus cancer	0.00173	0.00302	CcSEcCtD
Boceprevir—Pruritus—Octreotide—thymus cancer	0.0017	0.00298	CcSEcCtD
Boceprevir—ABCB1—hematopoietic system—thymus cancer	0.00166	0.00459	CbGeAlD
Boceprevir—Diarrhoea—Octreotide—thymus cancer	0.00165	0.00288	CcSEcCtD
Boceprevir—Dizziness—Octreotide—thymus cancer	0.00159	0.00279	CcSEcCtD
Boceprevir—Vomiting—Octreotide—thymus cancer	0.00153	0.00268	CcSEcCtD
Boceprevir—CMA1—Signaling by SCF-KIT—KIT—thymus cancer	0.00153	0.0223	CbGpPWpGaD
Boceprevir—Rash—Octreotide—thymus cancer	0.00152	0.00266	CcSEcCtD
Boceprevir—Dermatitis—Octreotide—thymus cancer	0.00151	0.00265	CcSEcCtD
Boceprevir—ABCB1—epithelium—thymus cancer	0.00151	0.0042	CbGeAlD
Boceprevir—Headache—Octreotide—thymus cancer	0.00151	0.00264	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CYLD—thymus cancer	0.00145	0.0212	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CYLD—thymus cancer	0.00145	0.0212	CbGpPWpGaD
Boceprevir—Nausea—Octreotide—thymus cancer	0.00143	0.0025	CcSEcCtD
Boceprevir—ABCB1—pituitary gland—thymus cancer	0.00123	0.00341	CbGeAlD
Boceprevir—CTSK—Innate Immune System—CYLD—thymus cancer	0.0012	0.0176	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—AKT1—thymus cancer	0.00118	0.0172	CbGpPWpGaD
Boceprevir—ABCB1—lymphoid tissue—thymus cancer	0.00117	0.00323	CbGeAlD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.0011	0.0161	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—thymus cancer	0.00107	0.0157	CbGpPWpGaD
Boceprevir—ABCB1—bone marrow—thymus cancer	0.00106	0.00294	CbGeAlD
Boceprevir—ABCB1—thyroid gland—thymus cancer	0.00106	0.00294	CbGeAlD
Boceprevir—CTSS—Innate Immune System—CYLD—thymus cancer	0.00099	0.0145	CbGpPWpGaD
Boceprevir—ABCB1—lung—thymus cancer	0.000962	0.00267	CbGeAlD
Boceprevir—CTSL—Immune System—CYLD—thymus cancer	0.000845	0.0124	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CYLD—thymus cancer	0.000845	0.0124	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CYLD—thymus cancer	0.0007	0.0102	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD8A—thymus cancer	0.000681	0.00995	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD8A—thymus cancer	0.000681	0.00995	CbGpPWpGaD
Boceprevir—ABCB1—lymph node—thymus cancer	0.000658	0.00182	CbGeAlD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—thymus cancer	0.000583	0.00852	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CYLD—thymus cancer	0.000577	0.00843	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD8A—thymus cancer	0.000564	0.00824	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KIT—thymus cancer	0.000532	0.00778	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KIT—thymus cancer	0.000532	0.00778	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KIT—thymus cancer	0.000511	0.00747	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—KIT—thymus cancer	0.000511	0.00747	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD8A—thymus cancer	0.000464	0.00679	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—KIT—thymus cancer	0.000441	0.00645	CbGpPWpGaD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.00043	0.00629	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KIT—thymus cancer	0.000424	0.00619	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD8A—thymus cancer	0.000413	0.00603	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD8A—thymus cancer	0.000413	0.00603	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CD4—thymus cancer	0.000407	0.00595	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CD4—thymus cancer	0.000407	0.00595	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAML2—thymus cancer	0.000404	0.0059	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD4—thymus cancer	0.000391	0.00571	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD4—thymus cancer	0.000391	0.00571	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KIT—thymus cancer	0.000363	0.00531	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KIT—thymus cancer	0.000349	0.0051	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD8A—thymus cancer	0.000342	0.005	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CD4—thymus cancer	0.000337	0.00493	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD4—thymus cancer	0.000324	0.00473	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KIT—thymus cancer	0.00031	0.00453	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KIT—thymus cancer	0.00031	0.00453	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD8A—thymus cancer	0.000282	0.00412	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CD4—thymus cancer	0.000278	0.00406	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD4—thymus cancer	0.000267	0.0039	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KIT—thymus cancer	0.000257	0.00375	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD4—thymus cancer	0.000237	0.00347	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD4—thymus cancer	0.000237	0.00347	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL2—thymus cancer	0.000218	0.00319	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL2—thymus cancer	0.000218	0.00319	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KIT—thymus cancer	0.000212	0.00309	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000207	0.00302	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—thymus cancer	0.000203	0.00297	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—thymus cancer	0.000203	0.00297	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD4—thymus cancer	0.000196	0.00287	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—thymus cancer	0.000195	0.00285	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—thymus cancer	0.000195	0.00285	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KIT—thymus cancer	0.000186	0.00272	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—thymus cancer	0.000181	0.00264	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—thymus cancer	0.000168	0.00246	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—thymus cancer	0.000162	0.00236	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—thymus cancer	0.000162	0.00236	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—thymus cancer	0.000149	0.00218	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—thymus cancer	0.000139	0.00203	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—thymus cancer	0.000133	0.00195	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—thymus cancer	0.000131	0.00192	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000129	0.00189	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—thymus cancer	0.000118	0.00173	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—thymus cancer	0.000118	0.00173	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—thymus cancer	9.8e-05	0.00143	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—thymus cancer	8.42e-05	0.00123	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—thymus cancer	8.07e-05	0.00118	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—thymus cancer	7.11e-05	0.00104	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	6.55e-05	0.000958	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	5.53e-05	0.000809	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—thymus cancer	1.36e-05	0.000199	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—thymus cancer	1.03e-05	0.00015	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—thymus cancer	6.34e-06	9.26e-05	CbGpPWpGaD
